Ironwood Pharmaceuticals IRWD
NASDAQ IRWD
$4.29 +0.15 (+3.62%)
At close: Aug 21, 2026 · 4:00 PM EDT

Ironwood Pharmaceuticals (IRWD) Amortizatization of Intangibles (2010 - 2018)

Ironwood Pharmaceuticals (IRWD) posted Amortizatization of Intangibles of $8000.0 for Q4 2018, down 57.89% sequentially from $19000.0 in Q3 2018, and down 92.45% YoY from $106000.0 in Q4 2017.

Ironwood Pharmaceuticals (IRWD) Amortizatization of Intangibles (2010 - 2018) Analysis & Trends

Ironwood Pharmaceuticals has reported Amortizatization of Intangibles for 9 years, with the latest figure at $8000.0 in Q4 2018.

  • Quarterly Amortizatization of Intangibles fell 92.45% year-over-year to $8000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $165000.0 (up 120.0% YoY) and the FY2018 annual result came in at $165000.0, up 120.0% from the prior year.
  • Amortizatization of Intangibles eased to $8000.0 in Q4 2018 per IRWD's latest filing, from $19000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $118000.0 in Q1 2018 and troughed at -$722000.0 in Q3 2015.
  • A 5-year average of -$133263.2 and a median of -$106000.0 in 2016 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2016 and 2018: Amortizatization of Intangibles sank 111.18% in 2016, then surged 433.33% in 2018.
  • Over 5 years, Amortizatization of Intangibles stood at -$261000.0 in 2014, then sank by 176.63% to -$722000.0 in 2015, then surged by 85.32% to -$106000.0 in 2016, then surged by 200.0% to $106000.0 in 2017, then tumbled by 92.45% to $8000.0 in 2018.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $8000.0, $19000.0, and $20000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 900,000.00
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Ironwood Pharmaceuticals 706.94 Mn 627.81 Mn - 453,000.00

Historic Data

Download Data
DateValue
Dec 31, 2018 8,000.00
Dec 31, 2018 8,000.00
Sep 30, 2018 19,000.00
Sep 30, 2018 19,000.00
Jun 30, 2018 20,000.00
Jun 30, 2018 20,000.00
Mar 31, 2018 118,000.00
Mar 31, 2018 118,000.00
Dec 31, 2017 106,000.00
Dec 31, 2017 106,000.00
Sep 30, 2017 80,000.00
Sep 30, 2017 80,000.00
Jun 30, 2017 -6,000.00
Jun 30, 2017 -6,000.00
Mar 31, 2017 -105,000.00
Mar 31, 2017 -105,000.00
Dec 31, 2016 -106,000.00
Dec 31, 2016 -106,000.00
Sep 30, 2016 -104,000.00
Sep 30, 2016 -104,000.00